@article{510dd0674aa445ed98d7d581fa7d8b14,
title = "Lung Cancer in Germany",
author = "Nikolaj Frost and Frank Griesinger and Hans Hoffmann and Florian L{\"a}nger and Ursula Nestle and Wolfgang Sch{\"u}tte and J{\"u}rgen Wolf and Martin Reck",
note = "Funding Information: Disclosure: Dr. Frost reports receiving consulting fees for advisory boards from AbbVie, United States, Amgen, United States, AstraZeneca, United Kingdom, BeiGene, Berlinchemie, Boehringer Ingelheim, Bristol-Myers Squibb, United States, Eli Lilly, Merck Sharpe \& Dohme, Merck, United States, Novartis, Pfizer, United States, Roche, Sanofi, and Takeda and support for attending meetings and/or travel from Amgen, AstraZeneca, Bristol-Myers Squibb, Janssen, United States, EliLilly, and Takeda. Dr. Griesinger reports receiving consulting fees for advisory boards from Roche, AbbVie, Merck, Merck Sharp \& Dohme, United Kingdom, Takeda, Boehringer Ingelheim, Germany, Sanofi, and Bristol-Myers Squibb; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Roche, AbbVie, Merck, Merck Sharp \& Dohme, Takeda, Boehringer Ingelheim, Sanofi, and Bristol-Myers Squibb; support for attending meetings and/or travel from Roche, AbbVie, Merck, Merck Sharp \& Dohme, Takeda, Boehringer Ingelheim, Sanofi, Bristol-Myers Squibb; and has participated on a data safety monitoring board or advisory board for Roche, AbbVie, Merck, Merck Sharp \& Dohme, Takeda, Boehringer Ingelheim, Sanofi, and Bristol-Myers Squibb. Dr. Nestle reports receiving consulting fees for advisory boards from AstraZeneca and Merck Sharp \& Dohme; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from AstraZeneca; and has a leadership or fiduciary role in other board, society, committee, or advocacy group, paid or unpaid for SSK (Radiation Protection Committee, vice chair), DEGRO (German Radiation Oncology Society, working group leader), and ESTRO (European Radiation Oncology Society, course director). Dr. Sch{\"u}tte reports receiving payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Boehringer Ingelheim, Roche, Merck Sharp \& Dohme, GlaxoSmithKline, Novartis, and Sanofi Aventis; and has participated in a data safety monitoring board or advisory board for Boehringer Ingelheim, Roche, Merck Sharp \& Dohme, GlaxoSmithKline, Novartis, and Sanofi Aventis. Dr. Wolf reports receiving research support to the institution from Bristol-Myers Squibb, Janssen Pharmaceutica, Novartis, Pfizer; consulting fees from Amgen, AstraZeneca, Bayer, Germany, Blueprint, Bristol-Myers Squibb, Boehringer Ingelheim, Chugai, Japan, Daiichi-Sankyo, Japan, Ignyta, United States, Janssen, Eli Lilly, Loxo, Merck Sharp \& Dohme, Novartis, Pfizer, Roche, Seattle Genetics, United States, and Takeda; payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Amgen, AstraZeneca, Bayer, Blueprint, Bristol-Myers Squibb, Boehringer Ingelheim, Chugai, Daiichi-Sankyo, Ignyta, Janssen, Eli Lilly, Loxo, Merck Sharp \& Dohme, Novartis, Switzerland, Pfizer, Roche, Switzerland, Seattle Genetics, and Takeda; and support for attending meetings and/or travel from Amgen, AstraZeneca, Bayer, Blueprint, Bristol-Myers Squibb, Boehringer Ingelheim, Chugai, Daiichi-Sankyo, Ignyta, Janssen, EliLilly, Loxo, Merck Sharp \& Dohme, Novartis, Pfizer, Roche, Seattle Genetics, and Takeda. Dr. Reck reports receiving payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing, or educational events from Amgen, AstraZeneca, Beigene, Bristol-Myers Squibb, Boehringer Ingelheim, Daiichi-Sankyo, Lilly, Merck, Merck Sharp \& Dohme, Novartis, Pfizer, Sanofi, United States, and Roche. The remaining authors declare no conflict of interest.",
year = "2022",
month = jun,
doi = "10.1016/j.jtho.2022.03.010",
language = "English",
volume = "17",
pages = "742--750",
journal = "Journal of Thoracic Oncology",
issn = "1556-0864",
publisher = "Elsevier Inc.",
number = "6",
}
SDG 3 Good Health and Well-being